Even stressed cells are individuals: Second messengers of free radicals in pathophysiology of cancer

Croatian Medical Journal

Volumn 53, Issue 4, 2012, Pages 304-309

  Jaganjac, Morana ^a   Čačev, Tamara ^a   Čipak, Ana ^a   Kapitanović, Sanja ^a   Trošelj, Koraljka Gall ^a   Žarković, Neven ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 5 HYDROXYMETHYLCYTOSINE; ACROLEIN; CARBONYL DERIVATIVE; DEOXYADENOSINE; DEOXYCYTIDINE; FREE RADICAL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

AMIDATION; ARTICLE; BASE MISPAIRING; CARCINOGENESIS; CELL STRESS; CHROMATIN CONDENSATION; DNA DAMAGE; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; EPIGENETICS; GAIN OF FUNCTION MUTATION; GENE MUTATION; GENE SILENCING; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LOSS OF FUNCTION MUTATION; MACROMOLECULE; MUTAGENIC ACTIVITY; OXIDATION; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN CARBONYLATION; PROTEIN CLEAVAGE; PROTEIN METABOLISM; TUMOR GROWTH;

ADAPTATION, PHYSIOLOGICAL; CELL PHYSIOLOGICAL PHENOMENA; CELL TRANSFORMATION, NEOPLASTIC; CELLS; DNA DAMAGE; HUMANS; INDIVIDUALIZED MEDICINE; LIPID PEROXIDATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL;

EID: 84866445031     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.304     Document Type: Article

References (44)

1. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem. 1997;272:20313-6
2. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem. 2008;283:21837-41
3. Suzuki YJ, Carini M, Butterfield DA. Protein carbonylation. Antioxid Redox Signal. 2010;12:323-5
4. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 2011;711:193-201
5. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567:1-61
6. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27:120-39
7. Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature. 2000;403:859-66
8. Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal. 2004;6:561-70
9. Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis. 2007;28:1851-8
10. alinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004;32:4100-8
11. Bienvenu C, Wagner JR, Cadet J. Photosensitized oxidation of 5-Methyl-2'-deoxycytidine by 2-Methyl-1,4-naphthoquinone: Characterization of 5-(Hydroperoxymethyl)-2'-deoxycytidine and stable methyl group oxidation product. J Am Chem Soc. 1996;118:11406-11.
12. Robertson J, Robertson AB, Klungland A. The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. Biochem Biophys Res Commun. 2011;411:40-3
13. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128
14. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23-38
15. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem. 2008;283:21837-41
16. Minko IG, Kozekov ID, Harris TM, Rizzo CJ, Lloyd RS, Stone MP. Chemistry and biology of DNA containing 1, N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol. 2009;22:759-78
17. Huang H, Kozekov ID, Kozekova A, Wang H, Lloyd RS, Rizzo CJ, et al. DNA cross-link induced by trans-4-hydroxynonenal. Environ Mol Mutagen. 2010;51:625-34
18. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A. 2000;97:12770-5
19. Kanuri M, Minko IG, Nechev LV, Harris TM, Harris CM, Lloyd RS. Error prone translesion synthesis past gammahydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. J Biol Chem. 2002;277:18257-65
20. Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, et al. c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factorbeta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med. 2006;41:443-54
21. Sunjic SB, Cipak A, Rabuzin F, Wildburger R, Zarkovic N. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. Biofactors. 2005;24:141-8
22. Jaganjac M, Matijevic T, Cindric M, Cipak A, Mrakovcic L, Gubisch W, et al. Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells. Acta Biochim Pol. 2010;57:179-83
23. Z arkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med. 2003;24:281-91
24. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1-3
25. Z ivkovic M, Poljak-Blazi M, Egger G, Sunjic SB, Schaur RJ, Zarkovic N. Oxidative burst and anticancer activities of rat neutrophils. Biofactors. 2005;24:305-12
26. Z ivkovic M, Poljak-Blazi M, Zarkovic K, Mihaljevic D, Schaur RJ, Zarkovic N. Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett. 2007;246:100-8
27. Jaganjac M, Poljak-Blazi M, Zarkovic K, Schaur RJ, Zarkovic N. The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma. Cancer Lett. 2008;260:180-6
28. Jaganjac M, Poljak-Blazi M, Kirac I, Borovic S, Schaur RJ, Zarkovic N. Granulocytes as effective anticancer agent in experimental solid tumor models. Immunobiology. 2010;215:1015-20
29. Jaganjac M, Poljak-Blazi M, Schaur RJ, Zarkovic K, Borovic S, Cipak A, et al. Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression. Clin Exp Immunol. 2012.
30. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008;266:6-11
31. Jeronimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst. 2001;93:1747-52
32. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70
33. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74
34. Ruckert F, Grutzmann R, Pilarsky C. Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas. PLoS ONE. 2012;7:e36719
35. Z arkovic K, Uchida K, Kolenc D, Hlupic LJ, Zarkovic N. Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res. 2006;40:543-52
36. Marquez-Quinones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Trevino S, Zarkovic N, et al. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res. 2010;44:119-27
37. Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G, et al. Differential effect of 4-hydroxynonenal on normal and malignant mesenchimal cells. Redox Rep. 2007;12:50-4
38. Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res. 2010;44:1172-202
39. Custovic Z, Zarkovic K, Cindric M, Cipak A, Jurkovic I, Sonicki Z, et al. Lipid peroxidation product acrolein as predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic Res. 2010;44:497-504
40. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, et al. Pathological aspects of lipid peroxidation. Free Radic Res. 2010;44:1125-71
41. Martini M, Vecchione L, Siena S, Tejpar S, Bardelli A. Targeted therapies: how personal should we go? Nat Rev Clin Oncol. 2011;9:87-97
42. Wu CH, Tang SC, Wang PH, Lee H, Ko JL. Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem. 2012;287:25292-302
43. Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med. 2012;271:111-21
44. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5:845-56